Evidence map›Paper›PMID 33199730›Full record

ArticleNature communications2020

RRP7A links primary microcephaly to dysfunction of ribosome biogenesis, resorption of primary cilia, and neurogenesis.

Muhammad Farooq, Louise Lindbæk, Nicolai Krogh, Canan Doganli, Cecilie Keller, Maren Mönnich, André Brás Gonçalves, Srinivasan Sakthivel, Yuan Mang, Ambrin Fatima and 13 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. VIRMA-mediated mScience advances · 2025
    Article
  9. Multi-omic analysis of the ciliogenic transcription factorbioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Case Report: Compound heterozygousFrontiers in genetics · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 4 countries.

Muhammad FarooqDepartment of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark.
Louise LindbækDepartment of Biology, University of Copenhagen, Universitetsparken 13, DK-2100, Copenhagen, Denmark.
Nicolai KroghDepartment of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark.
Canan DoganliDepartment of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark.
Cecilie KellerDepartment of Biology, University of Copenhagen, Universitetsparken 13, DK-2100, Copenhagen, Denmark.
Maren MönnichDepartment of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark.
André Brás GonçalvesDepartment of Biology, University of Copenhagen, Universitetsparken 13, DK-2100, Copenhagen, Denmark.
Srinivasan SakthivelDepartment of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark.
Yuan MangDepartment of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark.
Ambrin FatimaHuman Molecular Genetics Laboratory; Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering PIEAS, Jhang Road, 38000, Faisalabad, Punjab, Pakistan.
Vivi Søgaard AndersenDepartment of Biology, University of Copenhagen, Universitetsparken 13, DK-2100, Copenhagen, Denmark.
Muhammad S HussainInstitute of Biochemistry I, University of Cologne, Joseph-Stelzmann-Strasse 52, D50931, Cologne, Germany.ORCID 0000-0002-1353-8809
Hans EibergDepartment of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark.
Lars HansenDepartment of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark.
Klaus Wilbrandt KjaerDepartment of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark.
Jay GopalakrishnanInstitute of Human Genetics, Universitätsstrasse 1, Heinrich-Heine-University, D-40225, Düsseldorf, Germany.
Lotte Bang PedersenDepartment of Biology, University of Copenhagen, Universitetsparken 13, DK-2100, Copenhagen, Denmark.ORCID 0000-0002-9749-3758
Kjeld MøllgårdDepartment of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark.ORCID 0000-0002-6645-8626
Henrik NielsenDepartment of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark.ORCID 0000-0001-7143-2810
Shahid M BaigHuman Molecular Genetics Laboratory; Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering PIEAS, Jhang Road, 38000, Faisalabad, Punjab, Pakistan.
Niels TommerupDepartment of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark.
Søren Tvorup ChristensenDepartment of Biology, University of Copenhagen, Universitetsparken 13, DK-2100, Copenhagen, Denmark. stchristensen@bio.ku.dk.ORCID 0000-0001-5004-304X
Lars Allan LarsenDepartment of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, DK-2200, Copenhagen, Denmark. larsal@sund.ku.dk.ORCID 0000-0002-7536-1172
University of Copenhagen · DKNational Institute for Biotechnology and Genetic Engineering · PKHeinrich Heine University Düsseldorf · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary microcephaly (MCPH) is characterized by reduced brain size and intellectual disability. The exact pathophysiological mechanism underlying MCPH remains to be elucidated, but dysfunction of neuronal progenitors in the developing neocortex plays a major role. We identified a homozygous missense mutation (p.W155C) in Ribosomal RNA Processing 7 Homolog A, RRP7A, segregating with MCPH in a consanguineous family with 10 affected individuals. RRP7A is highly expressed in neural stem cells in developing human forebrain, and targeted mutation of Rrp7a leads to defects in neurogenesis and proliferation in a mouse stem cell model. RRP7A localizes to centrosomes, cilia and nucleoli, and patient-derived fibroblasts display defects in ribosomal RNA processing, primary cilia resorption, and cell cycle progression. Analysis of zebrafish embryos supported that the patient mutation in RRP7A causes reduced brain size, impaired neurogenesis and cell proliferation, and defective ribosomal RNA processing. These findings provide novel insight into human brain development and MCPH.

Indexed as

NeurogenesisOrganelle BiogenesisAdultAnimalsBase SequenceBrainCell CycleCell NucleolusCentrosomeCiliaFemaleFibroblastsHumansMaleMiceMicrocephalyNOL6 protein, humanNuclear ProteinsRNA-Binding ProteinsRNA, RibosomalRRP7A protein, human

Identifiers

PMID33199730
PMCPMC7670429
OpenAlexW3105009826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.